Cell Biologist Ruoslahti Nurtures While He Works

The name Erkki Ruoslahti appears so frequently below the titles of groundbreaking cell biology papers in top-quality journals, it should be a household word in cell laboratories by now. Three of his team’s papers have been listed among The Scientist’s ‘Hot Papers’ during the past three months; two other papers have made it into the Institute for Scientific Information’s Current Contents listing of the 100 most-cited life-sciences articles for 1986. Many Stars Wh

Written byKathryn Phillips
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The name Erkki Ruoslahti appears so frequently below the titles of groundbreaking cell biology papers in top-quality journals, it should be a household word in cell laboratories by now. Three of his team’s papers have been listed among The Scientist’s ‘Hot Papers’ during the past three months; two other papers have made it into the Institute for Scientific Information’s Current Contents listing of the 100 most-cited life-sciences articles for 1986.

While Ruoslahti’s name has been appearing with consistency, however, the names of his coauthors frequently change—not because he’s tough to work with, but because he seems to have a gift for developing the talents of colleagues who later move on to lead teams of their own.

Ruoslahti works at the 12-year-old La Jolla (Calif.) Cancer Research Foundation, where there are many stars among the cell biologists on its 150-person staff. For instance Eva Engvall, creator of the ELISA (enzyme-linked immunosorbent ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies